Clinical Research Fellow in Oncogenetics and Treatment Resistance

Sutton, London (Greater)
£36,675 per annum
01 Sep 2017
15 Oct 2017
Career Level
Contract Type
Fixed Contract
Full Time

Location: Sutton and London
Division: Genetics and Epidemiology
Team : Oncogenetics
Length of Contract : Three years
Hours per Week: 35
Salary Range: £36,675 per annum

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

Vacancy Description  

The Oncogenetics and Treatment Resistance Teams at The Institute of Cancer Research have a vacancy for a full time Clinical Research Fellow on a BRC-CRUK funded project involving sequencing of germline DNA for improved patient stratification in prostate cancer care. The postholder will work closely with the ICGC, PRACTICAL and STRATOSPHERE consortia. This is an exciting opportunity to work with multi-disciplinary consortia with the opportunity to receive training in a large range of research methodologies and drive a cutting edge research project aiming to implement the latest discoveries and technological developments in the field of germline and somatic genetics into clinical practice in prostate cancer care. The successful applicant will be fully integrated into the Oncogenetics and Treatment Resistance teams under the supervision of Professor Ros Eeles and Dr Gert Attard.

To apply please click on the apply button below.

Closing date: 15/10/2017 23:55

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff. We particularly welcome applications from women and people from ethnic minorities, as they are under-represented at the ICR at this level.